Estimate Recalculated Sep 9, 2024 12:29AM EST
Lawrence A Kenyon does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ALFACELL CORP, Outlook Therapeutics, Inc., PAR PHARMACEUTICAL COMPANIES, INC., Arno Therapeutics, Inc, and NEOPHARM INC.
Lawrence A Kenyon's CIK is 0001230484
2007 was Lawrence A Kenyon's most active year for acquiring shares with 7 total transactions. Lawrence A Kenyon's most active month to acquire stocks was the month of March. 2010 was Lawrence A Kenyon's most active year for disposing of shares, totalling 21 transactions. Lawrence A Kenyon's most active month to dispose stocks was the month of February. 2004 saw Lawrence A Kenyon paying a total of $398,200.00 for 20,000 shares, this is the most they've acquired in one year. In 2010 Lawrence A Kenyon cashed out on 50,087 shares for a total of $733,362.11, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!